Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

Journal of Experimental Medicine

Volumn 167, Issue 6, 1988, Pages 1767-1779

  Carbone, Francis R ^a   Moore, Mark W ^a   Sheil, James M ^a   Bevan, Michael J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL INDUCTION; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; H-2 ANTIGENS; IMMUNITY, CELLULAR; IN VITRO; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; OVALBUMIN; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0023772130     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.167.6.1767     Document Type: Article

References (37)

1. Zinkernagel, R. M., and P. C. Doherty. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (Lond.). 248: 701.
2. Doherty, P. C., and R. M. Zinkernagel. 1975. H-2 compatibility is required for T cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J. Exp, Med. 141: 502.
3. Bevan, M. J. 1975. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J. Exp. Med. 142: 1349.
4. Gordon, R. D., E. Simpson, and L. E. Samelson. 1975. In vitro cell-mediated immune responses to the male specific (HY) antigen in mice. J. Exp. Med. 142: 1108.
5. Gooding, L. R., and K. A. O’Connell. 1983. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J. Immunol. 131: 2580.
6. Townsend, A. R. M., F. M. Gotch, andJ. Davey. 1985. Cytotoxic T cells recognize fragments of influenza nucleoprotein. Cell. 42: 457.
7. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44: 959.
8. Maryanski, J. L., P. Pala, G. Corradin, B. R. Jordan, and J. C. Cerottini. 1986. H-2 restricted cytotoxic T cells specific for HLA can recognize a synthetic HLA peptide. Nature (Lond.). 324: 578.
9. McMichael, A. J., F. M. Gotch, andJ. Rothbard. 1986. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J Exp. Med. 164: 1397.
10. Germain, R. N. 1986. The ins and outs of antigen processing and presentation. Nature (Lond.). 322: 687.
11. Bevan, M. J. 1987. Class discrimination in the world of immunology. Nature (Lond.). 325: 192.
12. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature (Load.). 329: 506.
13. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (Lond.). 329: 512.
14. Matzinger, P., and M. J. Bevan. 1977. Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol. 29: 1.
15. Bevan, M. J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today. 5: 128.
16. Kaye, J., and C. A. Janeway, Jr. 1984. The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia.J. Exp. Med. 159: 1397.
17. Marshak-Rothstein, A., P. J. Fink, T. Gridley, D. H. Raulet, M. J. Bevan, and M. L. Gefter. 1979. Propertie s and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J. Immunol. 122: 2491.
18. Ceredig, R., J. W. Lowenthal, M. Nabholz, and H. R. MacDonald. 1985. Expression of interleukin 2 receptors as a differentiation marker on intrathymic stem cells. Nature (Lond.). 314: 98.
19. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol. 125: 2665.
20. − mouse lymphoma. Immunogenetics. 3: 75.
21. Winter, G., and S. Fields. 1981. The structure of the gene encoding the nucleoprotein of human influenza virus A/PR/8/34. Virology. 114: 423.
22. Bastin, J., J. Rothbard, J. Davey, I. Jones, and A. Townsend. 1987. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp. Med. 165: 1508.
23. Townsend, A. R. M., A. J. McMichael, N. P. Carter, J. A. Huddleston, and G. G. Brownlee. 1984. Cytotoxi c T cell recognition of the influenza nucleoprotein and haemagglutinin expressed in transfected mouse L cells. Cell. 39: 13.
24. Yewdell, J. W., J. R. Bennink, G. L. Smith, and B. Moss. 1985. Influenza A virus nucleoprotein is a major target antigen for cross reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 82: 1785.
25. Wagner, H., A. W. Harris, and M. Feldmann. 1972. Cell-mediated immune response in vitro II. The role of thymus and thymus-derived lymphocytes. Cell. Immunol. 4: 39.
26. MacDonald, H. R., R. A. Phillips, and R. G. Miller. 1973. Allograft immunity in the mouse. II. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.J. Immunol. 111: 565.
27. Alter, B. J., D. J. Schendel, M. L. Bach, F. H. Bach, J. Klein, and J. H. Stimpfling. 1973. Cell-mediate d lympholysis. Importance of serologically defined H-2 regions.J. Exp. Med. 137: 1303.
28. Shearer, G. M. 1974. Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes. Eur J Immunol. 4: 527.
29. Shearer, G. M., T. G. Rehn, and C. A. Garbarino. 1975. Cell-mediate d lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex. J Exp. Med. 141: 1348.
30. Unanue, E. R., D. I. Beller, C. Y. Lu, and P. M. Allen. 1984. Antigen presentation: comments on its regulation and mechanism. J Immunol. 132: 1.
31. Unanue, E. R. 1984. Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 2: 395.
32. Morrison, L. A., A. E. Lukacher, V. L. Braciale, D. Fan, and T. J. Braciale. 1986. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Exp. Med. 163: 903.
33. Braciale, T. J., L. A. Morrison, M. T. Sweetser, T. Sambrook, M. J. Gething, and V. L. Braciale. 1987. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98: 95.
34. Staerz, U. D., H. Karasuyama, and A. M. Garner. 1987. Cytotoxic T lymphocytes against a soluble protein. Nature (Lond). 329: 449.
35. Yap, K. L., G. L. Ada, and I. F. C. McKenzie. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (Lond.). 273: 238.
36. Lin, Y. L., and B. A. Askonas. 1981. Biological properties of an influenza A virus-specific killer T cell clone. J Exp. Med. 154: 225.
37. Lukacher, A. E., V. L. Braciale, and T. J. Braciale. 1984. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp. Med. 160: 814.